-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, the quality inspection public welfare industry scientific research special "important nucleic acid biotechnology 30 national standard development", the Chinese Academy of Sciences Institute of Microbiology participated in the "M-MLV reverse transcriptase and Bst polymerase national standard research" basically completed and in the National Standards Commission to form a draft for comments.
It is learned that the purpose of this study is to establish two tool enzyme product quality technical parameters of M-MLV reverse transcriptase and Bst polymerase, to form national standards for products, to promote tool enzyme production enterprises to improve the stability, specificity, enzyme activity, purity, etc. of their own products, and to promote the development of domestic tool enzyme production technology.
In recent years, the biotechnology industry technology field, especially nucleic acid biotechnology has appeared product quality stability is difficult to measure, inconsistent test results and other issues, the state has issued a series of policies or documents to regulate the biotechnology industry, the urgent need to have operational control means, standards or methods to support.
", on the one hand, to supplement important standards in a timely manner, on the other hand, these standards should be operability. Liu Wenjun, a researcher at the
Institute of Microbiology, said that the state has attached great importance to the problems in this field, and relevant departments have set up projects to develop testing methods and product technical standards that comply with nucleic acid biotechnology and other aspects to meet the objective needs of enterprise docking, technology and product standardization and management activities, and effectively realize the convenient trade in agricultural products.
this work is of great significance to promote the standardization and large-scale development of China's biotechnology industry, break through foreign technology monopoly, and lay the foundation of China's biotechnology industry and related industries.
" Chinese Academy of Sciences, using international cutting-edge technology, to build a national standard platform, research and development to establish technical standards in the field of nucleic acids as the main goal, for product quality improvement and industrial development services.
Jing Li, who is in charge of the special project of "China's Economic Development Project".
It is learned that, in addition to meeting the technical needs of the biopharmaceutical industry and drug regulatory, the Microbiology Institute will integrate other relevant units in biotechnology research and development base, with the biologics quality control common key technology development, standardization, testing services and promotion platform as the main way to build a radiation national biopharmaceutical enterprises within the system of the Chinese Academy of Sciences service network.
" at the same time, we should also be based on the training of a special nucleic acid-related technology product research and development and production of technical team, while taking the 'going out' and 'please come in' approach, with the relevant research institutes and enterprises to form a certain scale and relatively stable, can adapt to nucleic acid technology standardization and industrial development needs of the technical team.
," Liu wenjun said.
.